http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102091114-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102091114-B1 |
| titleOfInvention | Long-acting microspheres containing donepezil and process for preparing the same |
| abstract | The present invention relates to a long-acting long-acting microsphere comprising donepezil, a method for manufacturing the same, and a pharmaceutical composition for parenteral containing the microsphere, by preparing donepezil as a microsphere with a biodegradable polymer, initial drug release (initial burst) ) And in-vitro release of donepezil without lag time, and it is also possible to expect the effect of reducing the frequency of administration and maintaining the effective concentration in the blood for a long time by allowing the drug to be continuously released for a long time when administered in the body. . |
| priorityDate | 2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.